. Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemi

Author
EŞKAZAN, AHMET EMRE
GÜLTÜRK, Emine
SALİHOĞLU, Ayşe
EKİZOĞLU ERATAK, Seda
TANRIKULU ŞİMŞEK, Eda
ÖNGÖREN, Şeniz
DEMİRÖZ, AHU SENEM
CENGİZ, Mahir
AR, CEM
ELVERDİ, TUĞRUL
FERHANOĞLU, BURHAN
TÜZÜNER TUNÇAY, Nuriye Nukhet
AYDIN, Yıldız
SOYSAL, Teoman
BUYRU, Ayşe Nur
ÖZBEK, Uğur
BAŞLAR, Zafer
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/120928
Collections